Login
Navigate Fool.com
Will ALXN beat
the market?
Community Rating: 2 Stars: Unattractive

149.80 0.75 (0.50%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $149.27
Previous Close $149.05
Daily Range $147.30 - $154.11
52-Week Range $87.01 - $185.43
Market Cap $29.6B
P/E Ratio 117.36
Dividend (Yield) $0.00 (0.0%)
Volume 2,298,989
Average Daily Volume 2,129,935
Current FY EPS $3.90

How do you think ALXN
will perform against the market?

Top ALXN Bull/Bear Pitches

 

rh109605 (0)
Submitted February 14, 2007

I believe that this company's new cancer drug will draw in many investors over the next few months and the drug itself, which is in FDA review, looks like a definite winner. I suspect this stock to hi … More

3 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted February 22, 2010

Alexion is one of the most bizarre stories in biotech, building a 4.4B cap on the back of a single medication for a disease that only an estimated 10000 people in the entire world suffer from. By char … More

2 Replies Reply Report this Post

News & Commentary

How Are Orphan Drugmakers Faring in the Great Biotech Downturn?

Orphan drugmakers led the biotech rally upward. Is it now leading it downward?

Why Alexion Pharmaceuticals, Gilead Sciences, and Monster Beverage Corporation Are Today’s 3 Worst S

The tech and biotech meltdown continues, as growth stocks sell off en masse on Thursday.

S&P 500 Movers: BBBY, HPQ

Nasdaq 100 Movers: BBBY, CHRW

H-P tops S&P 500; Bed Bath & Beyond sags on outlook

Tweet of the Week: Big Biotech Dominates Industry Gains

Amgen, Biogen Idec, Celgene, Gilead Sciences, Regeneron Pharmaceuticals, and Alexion Pharmaceuticals make up 77% of the increase in the biotech sector over the past three years.

Investors continue to pour out of biotech holdings

Stifel Says Strong Earnings Will Reignite Biotech Rally

Noteworthy ETF Inflows: IBB, AMGN, BIIB, ALXN

1 Big Reason to Doubt the Biotech Bubble Chorus

Could the chorus of those singing that there's a biotech bubble bursting be off-key? Here's 1 reason to doubt the wisdom of the crowds.

See More ALXN News...

Sector

Healthcare

Industry

Drugs

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website: http://www.alexionpharm.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks